Harout Semerjian - 11 Nov 2022 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Chief Executive Officer, Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
GLYC
Transactions as of
11 Nov 2022
Net transactions value
+$32,250
Form type
4
Filing time
14 Nov 2022, 15:13:56 UTC
Previous filing
25 Jan 2022
Next filing
20 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Purchase $32,250 +25,000 $1.29 25,000 11 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.27 to $1.29 per share, with a weighted average purchase price of $1.29 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.